External validation of a multivariable risk-prediction tool (mediPORT) for identifying high-risk patients for a medication review - A prospective, national, multicenter observational study

External validation of a multivariable risk-prediction tool (mediPORT) for identifying high-risk patients for a medication review - A prospective, national, multicenter observational study - mediPORT 2.0 Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036595

Enrollment

150

Registered

2025-04-04

Start date

2025-04-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-related problem

Interventions

Group 1: All participants aged 18 and older who are capable of giving consent.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients capable of giving consent.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
•Sensitivity and Specificity of mediPORT, ROC and AUC	—

Secondary

Measure	Time frame
• Classification of durg-related problems according to the Pharmaceutical Care Network Europe Classification System • Classification of all active substances from medication and drug compounds leading to drug-related problems according to ATC • Economic benefit / fictive tool usage	—

Countries

Austria

Contacts

Public ContactStephanie Clemens

Paracelsus Medizinische Privatuniversität Salzburg

stephanie.clemens@pmu.ac.at+43 662 242080808

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026